Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

The committee noted that semaglutide tablets 3 mg, 7 mg, and 14 mg are approved for marketing in India. The firm has claimed ...

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

Half of the participants took a semaglutide tablet daily and half took a placebo. Participants continued their assigned regimen for an average of just under four years. By the end of the trial ...

The drug Fessler was taking when she suffered the agonizing side effect was semaglutide, a glucagon-like peptide-1 receptor agonist sold under the brand names Ozempic, Wegovy and Rybelsus.

The large-scale study focused on use of semaglutide and non-GLP-1 RAs. An increased risk for nonarteritic anterior ischemic optic neuropathy with semaglutide was seen at 2, 3 and 4 years from the ...

CHICAGO -- Semaglutide further solidified its efficacy ... Participants were told to take their assigned tablet in the morning, with a little water and no food or other medications until at ...